NewYork-Presbyterian Health reduced its workforce by 2%, or about 1,000 employees. Nurses voiced concerns that the layoffs unnecessarily harmed care.

The Cambridge biotech's wild ambitions for a powerful gene editing technology sank as the biotech market slumped.

CEO Keith Gottesdiener will be replaced by Prime's CFO as the company cuts 25% of its workforce and deprioritizes its lead ...